2020 Quality & Outcomes
Every three years, the American College of Surgeons’ Commission on Cancer surveys the Sentara Cancer Network to evaluate the effectiveness of the services provided, the utilization of multidisciplinary care, clinical quality, and the institution’s commitment to community outreach.
As part of these standards, the Commission on Cancer reviews clinical quality metrics to ensure the cancer program is in compliance and identifying any opportunities for improvement.
Multi-year performance is shown below with the US and Southeast region data acquired from the American College of Surgeons’ National Cancer Data Base (NCDB).
RADIATION THERAPY ADMINISTERED AFTER BREAST CONSERVING SURGERY
Radiation therapy is administered within 1 year of diagnosis for women under the age of 70 receiving breast conservation surgery for breast cancer.
Tamoxifen or third generation aromatase inhibitor is considered or administered within 1 year of diagnosis for women with T1cN0M0, or Stage IB-III hormone receptor positive breast cancer.
Radiation Therapy Administration Following Mastectomy
Radiation is recommended or administered following any mastectomy within 1 year (365 days) of diagnosis of breast cancer for women with 4 or more positive regional nodes.
NEEDLE BIOPSY TO ESTABLISH A DIAGNOSIS
Image or palpation-guided needle biopsy to the primary site is performed to establish diagnosis of breast cancer.
At least 12 regional lymph nodes are removed and pathologically examined for resected colon cancer.
At least 15 lymph nodes are removed and pathologically examined for resected gastric cancer.
SYSTEMIC CHEMOTHERAPY ADMINISTRATION
Systemic chemotherapy is administered within 4 months to day preoperatively or day of surgery to 6 months postoperatively, or it is recommended for surgically resected cases with pathologic lymph node-positive (pN1) and (pN2) NSCLC.
Lung No Surgery
Surgery is not the first course of treatment for cN2, M0 lung cases.
Preoperative chemo and radiation are administered for clinical AJCC T3N0, T4N0, or Stage III; or postoperative chemo and radiation are administered within 180 days of diagnosis for clinical AJCC T1-2N0 with pathologic AJCC T3N0, T4N0, or Stage III; or treatment is recommended for patients under the age of 80 receiving resection for rectal cancer.
Sentara Cancer Network Top 20 Tumor Sites 2020
Sentara Cancer Network Primary Site Tables
We collect data on cases diagnosed and treated at each facility in our network.
This table’s data is collected by the Sentara Cancer Network Registry Subcommittee from
the Hampton Roads region and other regional registrars.